Concert Pharmaceuticals Inc. logo

Concert Pharmaceuticals (CNCE) stock

CNCE · Concert Pharmaceuticals Inc. · NASDAQ

Website

What is the latest news on CNCE stock?

SECago
SEC Form 15-12G filed by Concert Pharmaceuticals Inc.

15-12G - CONCERT PHARMACEUTICALS, INC. (0001367920) (Filer)

All CNCE news

When does Concert Pharmaceuticals report earnings?

Concert Pharmaceuticals last reported on Nov 7, 2022, the date it announced on Oct 31, 2022. Before that it reported on Aug 4, 2022 and May 5, 2022.

CNCE earnings history

Latest news

25 items

Concert Pharmaceuticals Inc. (CNCE) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for CNCE in the last 30 days. The most recent was published Mar 16, 2023.

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. Its lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert Pharmaceuticals has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

CNCE FAQ

7 questions
  • What does Concert Pharmaceuticals Inc. do?
    Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. Its lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert Pharmaceuticals has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
  • Where does CNCE stock trade?
    Concert Pharmaceuticals Inc. (CNCE) is listed on NASDAQ.
  • What sector and industry is CNCE in?
    Concert Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Concert Pharmaceuticals Inc. go public?
    Concert Pharmaceuticals Inc. (CNCE) completed its IPO in 2014.
  • What are analysts saying about CNCE?
    Concert Pharmaceuticals Inc. has had 1 recent analyst action on file. The most recent action was from Mizuho: Buy with a $9.00 price target on 2021-10-05. Recent price targets cluster around $9.00.
  • What companies are similar to CNCE?
    Notable peers in the same industry include JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), ABT (Abbott Laboratories), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S). Compare CNCE side-by-side with any of them on Quantisnow.
  • How can I track CNCE on Quantisnow?
    Quantisnow aggregates Concert Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CNCE to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change